Medesis Pharma is planning an introduction to the stock market in the years 2018/2019. Capital increases are made each year to finance all research and development. To invest in the capital of our company, please use the contact section of the site
All capital contributions were exclusively made by private individuals. The company currently has 190 shareholders. We are mainly relying on capital infusions from our shareholders with a cumulated amount of €21 million injected in the Company capital over the last 14...
The storage or technical access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication on an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.Technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance by your ISP, or additional third-party records, information stored or retrieved for this purpose alone generally cannot be used to identify you.
Storage or technical access is required to create user profiles to send advertising, or to track the user across one or multiple websites for similar marketing purposes.